14-day Premium Trial Subscription Try For FreeTry Free

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of REVB
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Revelation Biosciences, Inc. stock price up 0.85% on Friday
(Updated on May 03, 2024)

Buy candidate since May 02, 2024 Gain 0.85% PDF

The Revelation Biosciences, Inc. stock price gained 0.85% on the last trading day (Friday, 3rd May 2024), rising from $2.35 to $2.37. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 5.65% from a day low at $2.30 to a day high of $2.43. The price has risen in 7 of the last 10 days and is up by 5.8% over the past 2 weeks. Volume fell on the last day by -40 thousand shares and in total, 24 thousand shares were bought and sold for approximately $57.87 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -25.88% during the next 3 months and, with a 90% probability hold a price between $1.16 and $2.43 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

REVB Signals & Forecast

The Revelation Biosciences, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $2.20 and $2.33. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Monday, April 15, 2024, and so far it has risen 29.86%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Revelation Biosciences, Inc. stock

Revelation Biosciences, Inc. finds support from accumulated volume at $2.36 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.130 between high and low, or 5.65%. For the last week the stock has had daily average volatility of 7.93%.

Our recommended stop-loss: $2.30 (-3.00%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 14 days ago.)

Trading Expectations (REVB) For The Upcoming Trading Day Of Monday 6th

For the upcoming trading day on Monday, 6th we expect Revelation Biosciences, Inc. to open at $2.37, and during the day (based on 14 day Average True Range), to move between $2.15 and $2.59, which gives a possible trading interval of +/-$0.218 (+/-9.21%) up or down from last closing price. If Revelation Biosciences, Inc. takes out the full calculated possible swing range there will be an estimated 18.41% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $2.36 (0.42%) than the resistance at $2.58 (8.86%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Revelation Biosciences, Inc. stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term.

Current score: 2.582 Buy Candidate Unchanged

Predicted Opening Price for Revelation Biosciences, Inc. of Monday, May 6, 2024

Fair opening price May 6, 2024 Current price
$2.37 ( 0.142%) $2.37

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for REVB

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.50 5.34 %
R2 2.45 3.25 %
R1 2.42 1.95 %
Current price: 2.37
Support S1 2.32 -2.24 %
S2 2.29 -3.53 %
S3 2.24 -5.62 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 2.78 17.30 %
R2 2.60 9.70 %
R1 2.58 8.86 %
Current price 2.37
Support S1 2.36 -0.422%
S2 2.24 -5.49%
S3 2.15 -9.28%

FAQ

What is the symbol for Revelation Biosciences, Inc. Stock and on which exchange is it traded?
The symbol for Revelation Biosciences, Inc. is REVB and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Revelation Biosciences, Inc. Stock?
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term.

How to buy Revelation Biosciences, Inc. Stock?
Revelation Biosciences, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Revelation Biosciences, Inc. Stock.

What's the current price of Revelation Biosciences, Inc. Stock?
As of the end of day on the May 03, 2024, the price of an Revelation Biosciences, Inc. (REVB) share was $2.37.

What is the 52-week high and low for Revelation Biosciences, Inc. Stock?
The 52-week high for Revelation Biosciences, Inc. Stock is $39.00 and the 52-week low is $1.78.

What is the market capitalization of Revelation Biosciences, Inc. Stock?
As of the May 03, 2024, the market capitalization of Revelation Biosciences, Inc. is 3.837M.

When is the next earnings date for Revelation Biosciences, Inc.?
The upcoming earnings date for Revelation Biosciences, Inc. is May 27, 2024.
Click to get the best stock tips daily for free!

About Revelation Biosciences, Inc.

Revelation Biosciences. Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. The company engages in developing therapeutic product candidates, including REVTx-99b that is in a Phase Ib clinical trial for the prevention or treatment of chronic nasal congestion and allergic rhinitis; and REVTx-200, a nonclinical stage product for intranasal therapy. It is a... REVB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT